SPDR S&P Biotech ETF

AMEX: XBI · Real-Time Price · USD
83.08
0.15 (0.18%)
At close: Jul 01, 2025, 3:59 PM
83.39
0.38%
After-hours: Jul 01, 2025, 07:13 PM EDT
0.18%
Bid 82.96
Market Cap 4.6B
AUM 4.95B
NAV 83.65
EPS (ttm) n/a
PE Ratio (ttm) n/a
Shares Out 55.35M
Inception Date Jan 30, 2006
Ask 83.19
Volume 10.91M
Open 82.46
Previous Close 82.93
Day's Range 82.04 - 84.87
52-Week Range 66.66 - 105.47
Holdings 123
Expense Ratio 0.35%

About XBI

The SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select IndustryTM Index (the “Index”)Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing

Asset Class Equity
Ticker Symbol XBI
Inception Date Jan 30, 2006
Provider State Street
Exchange AMEX

Top Sectors

Sector Weight %
Healthcare 100.00%
All Sectors

Top 10 Holdings 25.00% of assets

Name Symbol Weight
Exelixis, Inc. EXEL 2.66%
Alnylam Pharmaceutic... ALNY 2.62%
Insmed Incorporated INSM 2.60%
United Therapeutics ... UTHR 2.52%
Neurocrine Bioscienc... NBIX 2.48%
Natera, Inc. NTRA 2.48%
Regeneron Pharmaceut... REGN 2.42%
Incyte Corporation INCY 2.41%
Halozyme Therapeutic... HALO 2.41%
Vertex Pharmaceutica... VRTX 2.40%
View More Holdings

Dividends Dividend Yield 0.04%

Ex-Dividend Amount Payment Date
Jun 23, 2025 $0.0073 Jun 25, 2025
Mar 24, 2025 $0.0053 Mar 26, 2025
Dec 23, 2024 $0.0027 Dec 26, 2024
Sep 23, 2024 $0.0152 Sep 25, 2024
Jun 24, 2024 $0.1148 Jun 26, 2024
Full Dividend History
1 month ago
-6.63%
Shares of vaccine and gene therapy stocks are trad... Unlock content with Pro Subscription